Literature DB >> 29867137

Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.

Maura Knapp1, Xin Tu1, Rongxue Wu2.   

Abstract

Diabetes mellitus is currently a major public health problem. A common complication of diabetes is cardiac dysfunction, which is recognized as a microvascular disease that leads to morbidity and mortality in diabetic patients. While ischemic events are commonly observed in diabetic patients, the risk for developing heart failure is also increased, independent of the severity of coronary artery disease and hypertension. This diabetes-associated clinical entity is considered a distinct disease process referred to as "diabetic cardiomyopathy". However, it is not clear how diabetes promotes cardiac dysfunction. Vascular endothelial dysfunction is thought to be one of the key risk factors. The impact of diabetes on the endothelium involves several alterations, including hyperglycemia, fatty acid oxidation, reduced nitric oxide (NO), oxidative stress, inflammatory activation, and altered barrier function. The current review provides an update on mechanisms that specifically target endothelial dysfunction, which may lead to diabetic cardiomyopathy.

Entities:  

Keywords:  cardiomyopathy; diabetes; diabetic cardiovascular complications; endothelium; heart failure; metabolism; vascular

Mesh:

Substances:

Year:  2018        PMID: 29867137      PMCID: PMC6318313          DOI: 10.1038/s41401-018-0042-6

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  103 in total

1.  Mechanisms underlying endothelial dysfunction in diabetes mellitus.

Authors:  U Hink; H Li; H Mollnau; M Oelze; E Matheis; M Hartmann; M Skatchkov; F Thaiss; R A Stahl; A Warnholtz; T Meinertz; K Griendling; D G Harrison; U Forstermann; T Munzel
Journal:  Circ Res       Date:  2001-02-02       Impact factor: 17.367

2.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.

Authors:  L Virág; P Jagtap; E Szabó; J G Mabley; L Liaudet; A Marton; D G Hoyt; K G Murthy; A L Salzman; G J Southan; C Szabó
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

3.  Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression.

Authors:  Y Ding; N D Vaziri; R Coulson; V S Kamanna; D D Roh
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-07       Impact factor: 4.310

4.  Influence of diabetes on cardiac nitric oxide synthase expression and activity.

Authors:  K Stockklauser-Färber; T Ballhausen; A Laufer; P Rösen
Journal:  Biochim Biophys Acta       Date:  2000-12-15

5.  Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells.

Authors:  H Sone; B K Deo; A K Kumagai
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

6.  High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells.

Authors:  Z Zhang; K Apse; J Pang; R C Stanton
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

7.  Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes.

Authors:  S Y Yuan; E E Ustinova; M H Wu; J H Tinsley; W Xu; F L Korompai; A C Taulman
Journal:  Circ Res       Date:  2000-09-01       Impact factor: 17.367

8.  Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors.

Authors:  S Chen; T Evans; K Mukherjee; M Karmazyn; S Chakrabarti
Journal:  J Mol Cell Cardiol       Date:  2000-09       Impact factor: 5.000

9.  Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus.

Authors:  T Heitzer; K Krohn; S Albers; T Meinertz
Journal:  Diabetologia       Date:  2000-11       Impact factor: 10.122

10.  Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency.

Authors:  C J Meininger; R S Marinos; K Hatakeyama; R Martinez-Zaguilan; J D Rojas; K A Kelly; G Wu
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

View more
  52 in total

1.  Characteristics of Myocardial Perfusion in Type 2 Diabetes Mellitus and Its Association with Left Ventricular Diastolic Dysfunction: A Study of Myocardial Contrast Echocardiography.

Authors:  Yi Liu; Jing Ma; Jia Guo; Hao Lu; Yan Zhang; Yilei Chen
Journal:  Int J Gen Med       Date:  2021-11-02

2.  Fibronectin-Integrin α5 Signaling in Vascular Complications of Type 1 Diabetes.

Authors:  Minghao Chen; Rui Hu; Cristina Cavinato; Zhenwu W Zhuang; Jiasheng Zhang; Sanguk Yun; Pablo Fernandez Tussy; Abhishek Singh; Sae-Il Murtada; Keiichiro Tanaka; Min Liu; Carlos Fernández-Hernando; Jay D Humphrey; Martin A Schwartz
Journal:  Diabetes       Date:  2022-09-01       Impact factor: 9.337

Review 3.  The Beneficial Effects of Chinese Herbal Monomers on Ameliorating Diabetic Cardiomyopathy via Nrf2 Signaling.

Authors:  Yiwei Gao; Wu Liu; Xin Su; Xinyi Li; Fangning Yu; Ning Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-05-24       Impact factor: 7.310

4.  Capsaicin Alleviates Vascular Endothelial Dysfunction and Cardiomyopathy via TRPV1/eNOS Pathway in Diabetic Rats.

Authors:  Qiuyue Wang; Caihui Zhang; Chen Yang; Yue Sun; Keyang Chen; Yao Lu
Journal:  Oxid Med Cell Longev       Date:  2022-05-12       Impact factor: 7.310

Review 5.  Impact of stopping smoking on metabolic parameters in diabetes mellitus: A scoping review.

Authors:  Magdalena Walicka; Cristina Russo; Michael Baxter; Isaac John; Grazia Caci; Riccardo Polosa
Journal:  World J Diabetes       Date:  2022-06-15

6.  Salvianolic acid A promotes mitochondrial biogenesis and function via regulating the AMPK/PGC-1α signaling pathway in HUVECs.

Authors:  Xuelian Wang; Mi Zhang; Mengyao Zhang; Yantao Han; Xuehong Chen; Wenwen Zhao; Zhiwu Han; Jialin Sun
Journal:  Exp Ther Med       Date:  2022-06-01       Impact factor: 2.751

Review 7.  Regulation of carbohydrate metabolism by nitric oxide and hydrogen sulfide: Implications in diabetes.

Authors:  Sevda Gheibi; Alan P Samsonov; Shahsanam Gheibi; Alexandra B Vazquez; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-01-21       Impact factor: 5.858

8.  Angiotensin-converting enzyme 2 inhibits inflammation and apoptosis in high glucose-stimulated microvascular endothelial cell damage by regulating the JAK2/STAT3 signaling pathway.

Authors:  Yi Ren; Wei Xie; Song Yang; Ying Jiang; Danni Wu; Hao Zhang; Shiying Sheng
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 9.  Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response.

Authors:  Namrita Kaur; Yingshu Guan; Rida Raja; Andrea Ruiz-Velasco; Wei Liu
Journal:  Front Physiol       Date:  2021-06-21       Impact factor: 4.566

10.  Endothelial Aryl Hydrocarbon Receptor Nuclear Translocator Mediates the Angiogenic Response to Peripheral Ischemia in Mice With Type 2 Diabetes Mellitus.

Authors:  Tu Nguyen; Mei Zheng; Maura Knapp; Nikola Sladojevic; Qin Zhang; Lizhuo Ai; Devin Harrison; Anna Chen; Albert Sitikov; Le Shen; Frank J Gonzalez; Qiong Zhao; Yun Fang; James J K Liao; Rongxue Wu
Journal:  Front Cell Dev Biol       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.